Name: Harmony Biosciences Holdings, Inc. (HRMY) Financial Statements
Creator: FinSpry

Harmony Biosciences Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Harmony Biosciences Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	714.73	582.02	437.86	305.44	159.74
Cost of Revenue	156.82	121.24	83.48	55.52	27.74
Gross Profit	557.92	460.79	354.37	249.92	132.00
Operating Expenses
Research & Development	145.83	76.06	70.89	30.37	19.45
Selling, General & Administrative	221.27	192.69	163.30	132.03	95.57
Operating Expenses	367.09	268.76	234.19	162.39	115.02
Operating Income	190.83	192.03	120.19	87.53	16.99
Other Income/Expense
Interest Income	18.54	14.73	3.13	0.22	0.40
Interest Expense	17.50	-23.76	18.80	-24.19	-28.62
Other Income/Expense	-0.07	0.16	0.17	0.02	25.71
Income
Income Before Tax	191.80	173.40	104.69	37.43	-36.94
Income Tax Expense	46.31	44.54	-76.78	2.83	-6.42
Net Income	145.49	128.85	181.47	34.60	-36.94
Net Income - Continuous Operations	145.49	128.85	181.47	34.60	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	233.41	216.39	146.87	106.37	1.51
EBIT	209.30	192.03	123.48	87.53	-8.72
Depreciation & Amortization	24.11	24.36	23.39	18.84	10.24
Earnings Per Share
Basic EPS	3.00	2.00	3.00	1.00	-2.00
Diluted EPS	3.00	2.00	3.00	1.00	-2.00
Basic Shares Outstanding	56.89	59.47	59.17	57.53	25.77
Diluted Shares Outstanding	57.87	60.37	61.10	59.21	25.77